Navigation Links
Clinical Study Demonstrates Superior Bioavailability of Jarrow's Proprietary QH-absorb Formula
Date:6/13/2009

Clinical study demonstrates superior bioavailability of Jarrow Formula's proprietary ubiquinol Co-Q10 formula

Los Angeles, CA (PRWEB) June 13, 2009 -- The results of a clinical trial investigating the bioavailability of Jarrow Formulas®' QH-absorb®, a stabilized proprietary Co-Q10 formula utilizing the reduced form of Co-Q10 called ubiquinol, on 11 adult volunteers, was recently concluded at the medical school of the University of Ancona in Ancona, Italy.

Italian scientists from the University of Ancona (Institute of Biochemistry) measured the plasma level of Co-Q10 after taking 100 mg three times per day (100 mg T.I.D. = 300 mg). Eleven adult volunteers took Jarrow Formulas®' proprietary QH-absorb® formula over a 2-week period.

In this study, the results proved the superior absorption of QH-absorb®, as demonstrated by:

 
  • total Co-Q10 levels increasing from 0.70 mcg/mL to 6.14 mcg/mL.
  • improving the mean reduced Co-Q10 (ubiquinol) levels in the plasma from .62 mcg/ml to 5.75 mcg/mL. This was an increase of 827% over baseline in humans.
  • 5 of the volunteers achieved plasma levels over 7 mcg/mL and one subject was higher than 8 mcg/mL.

Another interesting finding showed a significant reduction in oxidized Co-Q10 in patients. Oxidized Co-Q10 does not function as an antioxidant. The results proved the efficacy of
'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS
2. Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal
3. Clinical Innovations Introduces New Circumcision Device
4. New Directions in Angioedema: A Focus on Etiologies and Clinical Approach
5. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
6. Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
7. Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
8. Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
9. Pharmasset Initiates Phase 1b Multiple Ascending Dose Clinical Trial of PSI-7851 in Chronic Hepatitis C Patients
10. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
11. Ross University School of Medicine Expands Clinical Rotations in Miami

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., TORONTO,Nov.25/PRNewswire/-SentinelleMedica...cedvisualizationsoftwarelaunchesasuiteofnewleading...ngsoftwareplatformatthisyear,sRadiologicalSocietyo...ec.5,2009(Booth5800,HallA).Theapplicationsleverage...pecializedMRIimagingcoilsandsupportmultipleimaging...
(Date:11/25/2009)..., LOSANGELES,Nov.25/PRNewswire-USNewswire/--T...ctionstodetermineexecutiveleadershipfor2010. ,,...withspecialtiesinpublicpolicy,law,finance,governme...ship.TheBoardalsocomesfromawiderangeofpersonalback...omen,somelivingwithHIVthemselves,andrepresentingmu...
(Date:11/25/2009)... Long-term survivors of testicular cancer who were...e severe side effects, including neurological side...were not treated with chemotherapy, according to a...urnal of the National Cancer Institute . , Maria...ukeland University Hospital, in Bergen, Norway, an...
(Date:11/25/2009)... Does stress increase blood pressure? This simple...or many years. New Stress-related gene Modulates ...crease blood pressure? This simple question has b... Now new research has for the first time establish... blood pressure response to stress in mice as well...
(Date:11/25/2009)... Evaluation and treatment ... Woodstock (Vocus) November 25, 2009 -- ... nasal vaccines and H1N1 vaccine shots at four Cen... another shipment of vaccine has arrived. The clin...l Lake and McHenry and will be open as follows: , ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...ormerly of Harvard University,s Office of General ... All Legal Aspects of the Company, WALTHAM, Mass....leading research and advisory firms for pharmaceut...ny. Ms.,Silver comes to Decision Resources with an...
...URLINGTON, Mass., July 24 Palomar Medical,Technol...of laser- and,light-based devices for hair removal...terly conference call of its 2008 second quarter f...Time on,that day. The telephone replay will be ava...
... Chicago, 24 July 2008 The editors of Neurothera...uly issue, devoted to "Novel Therapeutics for Alzh...neurotherapeutics.org/ ) is the journal of the Ame...nference on Alzheimer,s Disease (ICAD), being held...
...Mark,s Breathe Easy Tour, Inspires Those with Chro...Enjoy Life, SAN DIEGO, July 24 SeQual Technologi...rk,s Breathe Easy Tour," a,SeQual-sponsored initia...h as chronic obstructive pulmonary,disease (COPD)....
...ATESVILLE, Ind., July 24 Hill-Rom Holdings,Inc.,s...release will be,issued Wednesday, August 6, 2008. ...following morning on Thursday, August 7, 2008 at 8...eased to,the public after the NYSE close on Wednes...
...EXICO CITY, July 24 New research from the Journal...issue on HIV/AIDS will be,released to the media, c...Four of the world,s top HIV/AIDS researchers will ... is embargoed until,10 a.m. (CT) Sun., Aug. 3, 200...
Other Medicine News:Health News:Lori Silver Joins Decision Resources, Inc. as General Counsel 2Health News:Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008 2Health News:Neurotherapeutics presents special issue on new treatments for Alzheimer's disease 2Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 2Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 3Health News:SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride 4Health News:Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast 2
(Date:11/25/2009)...K,Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechn...amthatstopsseverebleeding,wonfirstprizeand$10,000i...curityChallenge2009,companyofficialsannouncetoday....world,Remedium,steampitchedtheirinventionattheGSCS...ness. ,, Remedium( www.remediumtechnologies.com...
(Date:11/25/2009)...v.25/PRNewswire/--Reportlinker.comannouncesthatane..., MammographyEquipment-AGlobalMarketPerspectiv...mmography-Equipment---A-Global-Market-Perspective....ializedaswellasdevelopingnationsisaprincipalfactor...scalatingawarenessaboutbreastcancerhasallowedwomen...
(Date:11/25/2009)...,N.C.,Nov.25/PRNewswire/--CempraPharmaceuticalsInc...ndchiefexecutiveofficer,willpresentatthePiperJaffr...mber1,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr...adingantibioticclinicalprogramsforthetreatmentofdr...mpraPharmaceuticals ,, Foundedin2006,CempraPha...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Lumenis Completes 2415 Million Equity Financing From New and Existing Investors 50469 1Lumenis Completes 2415 Million Equity Financing From New and Existing Investors 50469 2Lumenis Completes 2415 Million Equity Financing From New and Existing Investors 50469 3Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 1Psoriasis Cure Now Welcomes Institute of Medicine Report Urging Comparative Effectiveness Research on Psoriasis But Worries About Risk of Rationing 50467 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 1Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 2Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 3Barriers Hinder EMS Workers From Using Best Resuscitation Practices 50465 4
... Australia , May 22 The widely-used Affymetrix Wh...ay platform, normally used to assay gene expressio...ic splicing. Research published today in the open ... how to monitor alternative splicing activity on a...microarray technologies. , , Alternative splicing...
...-class treatment for inhalation anthrax - , , ROC...Nasdaq: HGSI ) today announced that it has submi...U.S. Food and Drug Administration (FDA) for its hu...mab) for the treatment of inhalation anthrax. , ...0080416/HGSLOGO ) , , The BLA submission incl...
Other Medicine Technology:Getting More From Whole-Transcript Microarrays 2Getting More From Whole-Transcript Microarrays 3Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 2Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 3Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM) 4
.../Cuff is specifically designed to treat children's...ic benefits of controlled compression to minimize ...in. Due to the unique design of the cuff, it can b...of the patient. The Pediatric Ankle Cryo/Cuff is i...
...is designed to stabilize the knee in full extensio...es the knee with cushioned straps, and is shaped t...tension. Because of its stability, lightweight des... ideal for post-op stabilization.,The Knee Immobi...
Front Closure Clavicle Support
Shoulder Stabilizer
Medicine Products: